Chad Briscoe, PhD
Scientific Officer / VP Business Development Europe
Overland Park, Kansas
Join Chad Briscoe, Ph.D., BioAgilytix Labs, for a live panel discussion with a few poster authors. Post your questions to the authors through a moderated chat-box.
The posters featured in this session include:
M1230-101 A Drug Tolerant Translational Approach for Measuring Anti-drug Antibodies in Non-clinical Studies, Rodd Polsky, GlaxoSmithKline
M1230-102 A Liquid Chromatography - Mass Spectrometry (LCMS) Approach for Quantitative Assessment of tau Protein Phosphorylation, Li Sun, Merck & Co., Inc.
M1230-103 Structural Characterization of Thermal-Stressed Trastuzumab by Covalent Labeling and Mass Spectrometry, Robert C. Vaughan, Ph.D., Catalent
M1230-104 Development of a Sensitive and Specific Assay to Measure Serum Anti-CAR Antibodies to an Autologous CAR-Treg Cell Therapy, Khaled Hettini, Sangamo Therapeutics
M1230-105 A Universal Method for the Quantitation of Multiple Oligonucleotides from Plasma by MFLC-MS/MS, Chad D. Christianson, Alturas Analytics, Inc.
M1230-106 Development and Pre-validation of a Duplex ddPCR Assay with Statistical Evaluation Using JMP, Stephen Higgins, MS, Smithers PDS